An ELISA DYRK1A non-radioactive assay suitable for the characterization of inhibitors
Authors:
Open Access
- 13 January 2017
- journal article
- Published by F1000 Research Ltd in F1000Research
- Vol. 6, 42
Abstract
The DYRK1A (dual specificity tyrosine phosphorylation-regulated kinase 1A) gene encodes a proline-directed Ser/Thr kinase. Elevated expression and/or altered distribution of the kinase have been implicated in the neurological impairments associated with Down syndrome (DS) and Alzheimer’s disease (AD). Consequently, DYRK1A inhibition has been of significant interest as a potential strategy for therapeutic intervention of DS and AD. Many classes of novel inhibitors have been described in the past decade. Although non-radioactive methods for analyzing DYRK1A inhibition have been developed, methods employing radioactive tracers are still commonly used for quantitative characterization of DYRK1A inhibitors. Here, we present a non-radioactive ELISA assay based on the detection of DYRK1A-phosphorylated dynamin 1a fragment using a phosphorylation site-specific antibody. The assay was verified by the use of two well-characterized DYRK1A inhibitors, epigallocatechin gallate (EGCG) and harmine. The IC50s for EGCG and harmine determined by the ELISA method were found to be comparable to those previously measured by radioactive tracing methods. Furthermore, we determined the mode of inhibition for EGCG and harmine by a modification of the ELISA assay. This assay confirms the mode of inhibition of EGCG (non-ATP-competitive) and harmine (ATP-competitive), as previously determined. We conclude that the ELISA platform demonstrated here is a viable alternative to the traditional radioactive tracer assays for analyzing DYRK1A inhibitors.Keywords
Funding Information
- This work is supported by the New York State Office for People with Developmental Disabilities
This publication has 39 references indexed in Scilit:
- Harmine is an ATP-competitive inhibitor for dual-specificity tyrosine phosphorylation-regulated kinase 1A (Dyrk1A)Archives of Biochemistry and Biophysics, 2011
- The role of DYRK1A in neurodegenerative diseasesThe FEBS Journal, 2010
- Development of a sensitive non-radioactive protein kinase assay and its application for detecting DYRK activity in Xenopus laevis oocytesBMC Biochemistry, 2010
- Overexpression of Dyrk1A contributes to neurofibrillary degeneration in Down syndromeThe FASEB Journal, 2008
- The selectivity of protein kinase inhibitors: a further updateBiochemical Journal, 2007
- Dual‐specificity tyrosine(Y)‐phosphorylation regulated kinase 1A‐mediated phosphorylation of amyloid precursor protein: evidence for a functional link between Down syndrome and Alzheimer’s diseaseJournal of Neurochemistry, 2007
- Kinetic Properties of a MNB/DYRK1A Mutant Suitable for the Elucidation of Biochemical PathwaysBiochemistry, 2006
- APP processing is regulated by cytoplasmic phosphorylationJournal of Cell Biology, 2003
- The specificities of protein kinase inhibitors: an updateBiochemical Journal, 2003
- A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye bindingAnalytical Biochemistry, 1976